Shawn R. Makinen

TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848)

Risini D. Weeratna, Shawn R. Makinen, Michael J. McCluskie et al. · Vaccine · 2005 · 167 citations

Vaccination, Cpg Odn, Cross-protection +13

Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse

Alain Vicari, Rachel Luu, Ningli Zhang et al. · Cancer Immunology Immunotherapy · 2008 · 134 citations · Full text

Cancer Immunosurveillance, Medicine, Immunology +10

Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters

Felicity C. Stark, Bassel Akache, Lise Deschatelets et al. · Scientific Reports · 2022 · 32 citations · Full text

CpG ODN and ISCOMATRIX Adjuvant: A Synergistic Adjuvant Combination Inducing Strong T-Cell IFN-<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mrow><mml:mi>γ</mml:mi></mml:mrow></mml:math>Responses

Michael J. McCluskie, Risini D. Weeratna, Dana M. Evans et al. · BioMed Research International · 2013 · 21 citations · Full text

CpG-mediated augmentation of CD8+ T-cell responses in mice is attenuated by a water-in-oil emulsion (Montanide ISA-51) but enhanced by an oil-in-water emulsion (IDRI SE)

Shawn R. Makinen, Qin Zhu, Heather L. Davis et al. · International Immunology · 2016 · 14 citations · Full text

T-regulatory Cell, Innate Immune System, Immunology +23